The Correlation Between Platelet Activation Markers and HMGB1 in Patients with Disseminated Intravascular Coagulation and Hematologic Malignancy
Overview
Authors
Affiliations
Platelet dysfunction after trauma: From mechanisms to targeted treatment.
Sloos P, Vulliamy P, Veer C, Sen Gupta A, Neal M, Brohi K Transfusion. 2022; 62 Suppl 1:S281-S300.
PMID: 35748694 PMC: 9546174. DOI: 10.1111/trf.16971.
Kim H, Hong M, Yoon J, Kim D, Na S, Jang Y Nutrients. 2020; 12(10).
PMID: 33050676 PMC: 7601160. DOI: 10.3390/nu12103096.
High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.
Yuan S, Liu Z, Xu Z, Liu J, Zhang J J Hematol Oncol. 2020; 13(1):91.
PMID: 32660524 PMC: 7359022. DOI: 10.1186/s13045-020-00920-3.
Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K Medicine (Baltimore). 2018; 97(44):e12981.
PMID: 30383650 PMC: 6221668. DOI: 10.1097/MD.0000000000012981.
Mardente S, Mari E, Massimi I, Tafani M, Guerriero R, Morsilli O Front Immunol. 2018; 8:1946.
PMID: 29375570 PMC: 5770369. DOI: 10.3389/fimmu.2017.01946.